✦ LIBER ✦

PIN35 CLINICAL EFFECTIVENESS AND COST UTILITY OF ENTECAVIR VERSUS LAMIVUDINE AND ADEFOVIR IN CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IN MEXICO

✍ Scribed by K. Rely; A. Juarez-Garcia; G. Salinas Escudero; G. Martinez-Rivera; P.K. Alexandre; B.M. Donato

Book ID: 119309434
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 55 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.666

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN10 COST EFFECTIVENESS OF ENTECAVIR VE

PIN10 COST EFFECTIVENESS OF ENTECAVIR VERSUS LAMIVUDINE IN SUPPRESSING VIRAL REPLICATION TO UNDETECTABLE GOAL IN CHRONIC HEPATITIS B (CHB) PATIENTS IN BRAZIL

✍ Nita, M; Litalien, G; Cure-Bolt, N; Mantilla, P; Araujo, E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PIN7 THE COST-EFFECTIVENESS OF ENTECAVIR

PIN7 THE COST-EFFECTIVENESS OF ENTECAVIR IN THE LONGTERM TREATMENT OF NUCLEOSIDE-NAÏVE AND LAMIVUDINE-REFRACTORY CHRONIC HEPATITIS B PATIENTS IN SWEDEN

✍ KH Cerri; Y Yuan; DC Zammit 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

558 COST-EFFECTIVENESS SIMULATION ANALYS

558 COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR), LAMIVUDINE, ADEFOVIR DIPIVOXIL (ADEFOVIR) AND ENTECAVIR OF HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS-B (CHB) IN SPAIN

✍ B. Deniz; M. Buti; M. Brosa; M.A. Casado; M. Rueda; F. Everhard; R. Esteban 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

Cost-effectiveness analysis of lamivudin

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

✍ M. BUTI; M. A. CASADO; J. L. CALLEJA; J. SALMERÓN; J. AGUILAR; M. RUEDA; R. ESTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Long-term efficacy of entecavir in adefo

Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance

✍ J. W. Park; H. S. Kim; D. D. Seo; J. S. Jang; W. G. Shin; K. H. Kim; M. K. Jang; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB